Gene · 1
NIH grants1,483
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 1,483
Download this page as JSON| Grant | Title | A1BG papers | Newest fiscal year |
|---|---|---|---|
| R01CA072038 | Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis | 1 | 2025 |
| R01CA102184 | Functional Analysis of p53 Polymorphic Variants | 1 | 2025 |
| R01CA137008 | Non-genomic resistance mechanisms in EGFR-mutant lung cancer | 1 | 2025 |
| R01CA167413 | Advancing molecular fluorescence-guided surgery platform | 1 | 2025 |
| R01CA251555 | Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches | 1 | 2025 |
| R01CA287294 | Academic-Industrial Partnership for Barrett's Esophagus Detection and Risk Assessment | 1 | 2025 |
| R01DA035714 | Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1Tat and cocaine | 1 | 2025 |
| R01DA057866 | Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse | 1 | 2025 |
| R01DK060581 | Transcriptional and Translational Mechanisms Governing Beta Cell Function | 1 | 2025 |
| R01DK072381 | Kidney Injury Molecule-1 in Epithelial Repair | 1 | 2025 |
| R01DK084842 | Prevention of Placental Insufficiency Improves Beta-Cells Function | 1 | 2025 |
| R01DK105448 | Genetic and Metabolic Basis of Familial Lipodystrophies | 1 | 2025 |
| R01DK107740 | VisR Ultrasound for Monitoring Antibody-Mediated Rejection in Renal Transplant Patients | 1 | 2025 |
| R01ES028271 | Investigation of human DNA polymerase epsilon variants | 1 | 2025 |
| R01ES034250 | STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | 1 | 2025 |
| R01EY011500 | Structure-function studies of visual arrestin | 1 | 2025 |
| R01EY017061 | Signaling Mechanisms of Lens Development | 1 | 2025 |
| R01EY022979 | A cell-type specific explanation of visual decision circuits. | 1 | 2025 |
| R01EY026202 | Lacrimal Gland Repair Using Progenitor Cells | 1 | 2025 |
| R01GM147545 | Development of a Novel Technology for Preparative Fractionation and Characterization of Lipoprotein Particles | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1/grants?page=6